Oragenics, Inc. is a biotechnology development-stage company incorporated in Florida in 1996 and headquartered in Lakewood Ranch, Florida. It is dedicated to fighting infectious diseases, including coronaviruses and multidrug-resistant pathogens.
Subscribe to see Oragenics Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Oragenics Inc. is a biotechnology company headquartered in Lakewood Ranch, United States. It is publicly listed (OGEN) with a market capitalisation of $2.3M. Xcout tracks 14 named people at Oragenics Inc., including Janet Huffman (CEO, President, Secretary & Treasurer).
8 more named people on record for Oragenics Inc., with roles, board committees and tenure — see the full roster →
A few of Oragenics Inc.'s closest competitors — see the full list of competitors and alternatives →
This biopharmaceutical company is dedicated to developing innovative antimicrobial therapies. Its array of anti-infective products is designed to tackle specific viral conditions, including avian influenza, Epstein-Barr Virus (EBV), and hepatitis B and C. Established by Roderic Dale on July 11, 2006, the firm maintains its principal office in Bradenton, Florida.
Omnix Medical is a biopharmaceutical company that develops novel antibiotic agents and antimicrobial peptides to treat infections caused by drug-resistant bacteria. The company focuses on creating first-in-its-class anti-infective therapeutics, such as its lead compound OMN6, to target life-threatening bacterial strains.
Ora Biomedical, Inc. is a longevity biotechnology pharmaceutical company headquartered in Tukwila, Washington, that identifies and develops longevity therapeutics and small molecules.
Orgenesis Inc. is a public biotechnology company founded in 2012. It has its primary headquarters located in Germantown, Maryland, United States.
Pardes Biosciences, Inc. is a clinical-stage biopharmaceutical company based in Carlsbad, California. The company focuses on the development of novel oral antiviral treatments for viral diseases.
Vaxart, Inc. is an American biotechnology company focused on the discovery, development, and commercialization of oral recombinant vaccines administered using temperature-stable tablets that can be stored and shipped without refrigeration, eliminating the need for needle injection. Its development programs for oral vaccine delivery include prophylactic, enteric-coated tablet vaccines for inhibiting norovirus, seasonal influenza, respiratory syncytial virus, and human papillomavirus. It was founded in 2004 by Sean Tucker. Originally incorporated as West Coast Biologicals, Inc. in California in
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.